Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,549 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00565227 | Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. | terminated | Phase 1 | 12 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 2, 2016 | clinicaltrials |
| NCT00637390 | A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. | terminated | Phase 1 | 3 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 2, 2016 |
| clinicaltrials |
| NCT02404428 | Utilizing MRI to Study the Effect of Sulforaphane on Prostate Cancer(ESCAPE-ING) | terminated | N/A | 5 | Quadram Institute BioscienceOTHER | 1 | Nov 25, 2016 | clinicaltrials |
| NCT01061606 | Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus | terminated | Phase 2 | 8 | National Cancer Institute (NCI)NIH | 1 | Nov 9, 2016 | clinicaltrials |
| NCT00933426 | Lenalidomide and Paclitaxel in Prostate Cancer | terminated | Phase 1 | 17 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 26, 2016 | clinicaltrials |
| NCT01144169 | Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma | terminated | Phase 1 | 7 | University of PittsburghOTHER | 1 | Oct 26, 2016 | clinicaltrials |
| NCT01227941 | MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011) | terminated | Phase 1 | 6 | Tesaro, Inc.INDUSTRY | 0 | Oct 19, 2016 | clinicaltrials |
| NCT01705405 | Merging of Endoscopic and Ultrasound Images for Laparoscopic Surgery(FEE) | terminated | N/A | 2 | AdministrateurCICOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT01761812 | Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods | terminated | N/A | 5 | Sunnybrook Health Sciences CentreOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT02279576 | Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)(PAZOPEN-SOGUG) | terminated | Phase 2 | 4 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT00862836 | Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD)(ZACFAST) | terminated | Phase 1 / Phase 2 | 15 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Oct 10, 2016 | clinicaltrials |
| NCT01032447 | Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program | terminated | — | 45 | Stanford UniversityOTHER | 1 | Sep 28, 2016 | clinicaltrials |
| NCT01829971 | A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | terminated | Phase 1 | 155 | Mirna Therapeutics, Inc.INDUSTRY | 2 | Sep 27, 2016 | clinicaltrials |
| NCT00590967 | A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy | terminated | Phase 2 | 69 | Washington University School of MedicineOTHER | 1 | Aug 29, 2016 | clinicaltrials |
| NCT02030574 | Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin | terminated | Phase 2 | 2 | Brown UniversityOTHER | 1 | Aug 24, 2016 | clinicaltrials |
| NCT02469116 | Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma | terminated | Phase 2 | 18 | Washington University School of MedicineOTHER | 1 | Aug 19, 2016 | clinicaltrials |
| NCT00022633 | S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract | terminated | Phase 2 | 65 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 11, 2016 | clinicaltrials |
| NCT01555073 | Preemptive Analgesia Following Uterine Artery Embolization | terminated | Phase 4 | 23 | Northwestern UniversityOTHER | 1 | Jul 28, 2016 | clinicaltrials |
| NCT00318110 | Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 4 | Center for International Blood and Marrow Transplant ResearchNETWORK | 1 | Jul 26, 2016 | clinicaltrials |
| NCT01336231 | Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer(COG-ANGIO) | terminated | — | 82 | Centre Francois BaclesseOTHER | 1 | Jul 21, 2016 | clinicaltrials |
| NCT01481441 | Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer(AMC_2011_190) | terminated | N/A | 208 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT01326390 | Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma | terminated | — | 13 | Stanford UniversityOTHER | 1 | Jul 1, 2016 | clinicaltrials |
| NCT00861471 | Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer | terminated | Phase 1 / Phase 2 | 24 | NYU Langone HealthOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT01003938 | Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer | terminated | Phase 2 | 6 | NYU Langone HealthOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT00003682 | Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer | terminated | Phase 3 | 160 | UNICANCEROTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT00003852 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors | terminated | Phase 2 | 45 | UNICANCEROTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT01339000 | Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy | terminated | Phase 2 | 1 | National Cancer Institute (NCI)NIH | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02140138 | An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer | terminated | Phase 2 | 35 | CureVacINDUSTRY | 1 | Jun 13, 2016 | clinicaltrials |
| NCT00503984 | A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients | terminated | Phase 1 / Phase 2 | 22 | University of MiamiOTHER | 1 | Jun 9, 2016 | clinicaltrials |
| NCT00671606 | Hysteroscopic Lymphatic Mapping for Endometrial Cancer | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | May 27, 2016 | clinicaltrials |
| NCT00216060 | Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy | terminated | Phase 3 | 63 | Christopher Sweeney, MBBSOTHER | 2 | May 26, 2016 | clinicaltrials |
| NCT00985738 | Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer | terminated | Phase 2 | 16 | University of Colorado, DenverOTHER | 1 | May 17, 2016 | clinicaltrials |
| NCT00529464 | Spectroscopy Versus Standard Care in Cervical Cancer Patients | terminated | Phase 3 | 2 | M.D. Anderson Cancer CenterOTHER | 2 | May 9, 2016 | clinicaltrials |
| NCT01981707 | F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer(PRECHOL) | terminated | Phase 2 / Phase 3 | 12 | University Hospital, GrenobleOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT02749825 | Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | terminated | Phase 4 | 41 | PharmatechINDUSTRY | 1 | Apr 25, 2016 | clinicaltrials |
| NCT01832831 | Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical Prostatectomy | terminated | — | 24 | University of MichiganOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT00243646 | Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial | terminated | Phase 3 | 6 | Schiffler Cancer CenterOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02479178 | A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck(iNSITE2) | terminated | Phase 2 | 73 | BIND TherapeuticsINDUSTRY | 2 | Apr 14, 2016 | clinicaltrials |
| NCT00024167 | Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | terminated | Phase 3 | 265 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT00831480 | Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal | terminated | Phase 2 | 15 | Linda C. HigginsOTHER | 1 | Mar 21, 2016 | clinicaltrials |
| NCT00440973 | Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer | terminated | Phase 2 | 6 | The Methodist Hospital Research InstituteOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT00522249 | Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC | terminated | Phase 1 / Phase 2 | 10 | The Methodist Hospital Research InstituteOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT01603420 | External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer | terminated | Phase 2 / Phase 3 | 2 | Proton Collaborative GroupNETWORK | 1 | Mar 14, 2016 | clinicaltrials |
| NCT01675011 | Embozene Microspheres for Uterine Fibroid Embolization (UFE) | terminated | N/A | 4 | Boston Scientific CorporationINDUSTRY | 1 | Mar 11, 2016 | clinicaltrials |
| NCT00526799 | Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer | terminated | Phase 1 / Phase 2 | 30 | Daniela Matei, MDOTHER | 1 | Mar 3, 2016 | clinicaltrials |
| NCT01220427 | Micro-RNA Expression Profiles in High Risk Prostate Cancer | terminated | — | 300 | Wuerzburg University HospitalOTHER | 1 | Mar 3, 2016 | clinicaltrials |
| NCT00522301 | Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission | terminated | Phase 2 | 6 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 29, 2016 | clinicaltrials |
| NCT00122265 | Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer | terminated | — | 83 | AHS Cancer Control AlbertaOTHER | 1 | Feb 26, 2016 | clinicaltrials |
| NCT00523471 | Blood Test to Measure DNA Damage in Blood | terminated | — | 40 | AHS Cancer Control AlbertaOTHER | 1 | Feb 26, 2016 | clinicaltrials |
| NCT01916109 | Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer | terminated | Phase 2 | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 12, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Dec 2, 2016source: clinicaltrials